Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
Currently there is neither a vaccine nor an effective treatment strategy available for COVID19. Here, Hurlburt et al. provide the crystal structure of a patient-derived monoclonal antibody neutralizing SARS-CoV-2 via shedding of the S1 subunit and competing for the receptor binding domain.
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2020
|
| Subjects: | |
| Online Access: | https://doaj.org/article/db69f59e4cb349f0a8827bbe7916aae3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|